Chiesi Pharmaceuticals GmbH
Chiesi Pharmaceuticals GmbH
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients | Prophylaxis Against Liver Transplant Rejection | Active, not recruiting | Phase 4 | 2025-04-06 | NCT04720326 | |
| Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs | Immunosuppression | Recruiting | Phase 4 | 2024-05-16 | NCT06268769 |